Results 281 to 290 of about 1,293,835 (325)

Unexpectedly competent immune response to SARS-CoV-2 vaccination in Rett syndrome. [PDF]

Hum Vaccin Immunother
Soldateschi L, Leoncini S, Fiorino F, Lucchesi S, Polvere J, Boasiako L, Pastore G, Fazzi C, Altamura M, Scandurra V, Grosso S, Montagnani F, De Felice C, Ciabattini A, Medaglini D.   +14 more
europepmc   +1 more source

When protein losing enteropathy persists: A case series of viral and lymphatic‐associated etiologies

JPGN Reports, EarlyView.
Abstract Protein‐losing enteropathy (PLE) is a rare condition that is characterized by loss of plasma protein in the intestines leading to hypoproteinemia with subsequent peripheral edema and possibly anasarca. The pathophysiology of PLE varies depending on the etiology and involves either intestinal mucosal injury or lymphatic system alterations ...
Natalie Jennings, Antonia C. Rovira, Pamela Castillo Rocha, Janelle Torres, Claudia M. Salgado, Miguel Reyes‐Múgica, Richard N. Arboleda, Fatima S. Hussain   +7 more
wiley   +1 more source

Lung infection in orally inoculated SARS-CoV-2 hamsters. [PDF]

PLoS One
Picard-Meyer E, Wasniewski M, Boué F, Torres-Maravilla E, Saint-Criq V, Larcher T, Beissat K, Jacouton E, Holowacz S, Waligora-Dupriet AJ, Langella P, Servat A, Monchatre-Leroy E.   +12 more
europepmc   +1 more source

Identification of Clinical Factors Associated With the Immunogenicity of Homologous ChAdOx1‐nCoV‐19 Vaccine in Hemodialysis Patients

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Hemodialysis (HD) patients are at higher risk of severe COVID‐19 and may exhibit suboptimal vaccine responses. This study evaluates the factors influencing vaccine‐induced immunity in HD patients following the second dose of the Vaxzevria. A total of 276 HD patients and 126 controls were included. Antibody responses were assessed using binding
Chia‐Wei Chang, Ping‐Hsun Wu, Li‐Yun Chang, Yu‐Ying Huang, Teng‐Hui Huang, Su‐Chu Lee, Yi‐wen Chiu, Shang‐Jyh Hwang, Tsun‐Yung Kuo, Mei‐Chuan Kuo   +9 more
wiley   +1 more source

Decoding the cross-immune pressure: Dengue's role in SARS-CoV-2 evolution. [PDF]

Comput Struct Biotechnol J
Mallick A, Chhajer R, Biswas S.
europepmc   +1 more source

A Non‐Antigenic Randomized Polyethylene Glycol/Poly(2‐Phenyl‐2‐Oxazine)‐Based Drug Delivery Platform

Macromolecular Rapid Communications, EarlyView.
Randomized PEG (rPEG), a conceptually new PEG alternative, is combined with poly(2‐phenyl‐2‐oxazine) (PPheOzi) to establish an rPEG‐b‐PPheOzi‐b‐rPEG micellar drug delivery platform. The PPheOzi block enables high drug loadings, while competitive ELISA reveals a drastic reduction in anti‐PEG antibody affinity of rPEG in comparison to PEG.
Julian Schmidt, Anna‐Lena Ziegler, Florian T. Kaps, Laura J. Rosenberger, Matthias Bros, Holger Frey, Robert Luxenhofer   +6 more
wiley   +1 more source

Structural Adaptability of IgA and IgM Supports Broad SARS-CoV-2 Variant Neutralization. [PDF]

J Med Virol
Pisil Y, Shida H, Ruiz SM, Cho K, Gungor M, Yazici Z, Miura T.   +6 more
europepmc   +1 more source

Active Learning for the Discovery of Antiviral Polymers

Macromolecular Rapid Communications, EarlyView.
Machine learning and active learning are integrated to accelerate the discovery of antiviral polymers. Molecular descriptors derived from polymer composition enable predictive modeling of antiviral activity, while unsupervised clustering explores chemical diversity. The active learning workflow identifies optimal candidates for synthesis, demonstrating
Clodagh M Boland, Nhat Quynh Nguyen, Nathan RB Boase   +2 more
wiley   +1 more source